about
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkCan ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?Breast Cancer Update 2014 - Focus on the Patient and the Tumour.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.Advances in Breast Cancer - Looking Back over the Year.Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryEpidemiology of Breast Cancer - Current Figures and TrendsParticipation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer.Assessment of University Gynaecology Clinics Based on Quality Reports.Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registryEvaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancerIdentification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers.Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians
P2860
Q31107007-69B2BECF-D7C3-4051-8674-49B3D20EE318Q34485182-2F7A6B59-2F51-42DC-9336-2C1D96304473Q35054455-BD5FB24E-DB0D-40B1-A0B9-B42D75EB07B7Q35160045-E5B61B27-22A3-423C-AFB6-6214C80388F4Q35180940-1E4B08AD-7798-4996-BF52-FE31B544F38BQ35427994-3DAA58C2-5156-42A3-B56C-55B8EEFB4EB3Q36295107-8FDBE4E2-806A-4507-8604-70DB7C1CCC27Q36892788-58E49732-3693-4144-9C46-86D8D554EEF5Q37382844-247ED324-0444-4D8E-BFF4-FB5ADBAA3A13Q37382870-21D79914-4C18-4F5D-B45B-F44DED5162BEQ37383194-A9C3407A-C33A-4005-A4C5-6BF16ED18060Q37631322-43F93FE4-1AFB-45ED-B67A-223C8BC5BAD3Q37660589-03755D97-101D-42E9-BFCE-925ED5966CA8Q37687943-FECBDFF0-885A-4E38-837D-58641AD1463AQ37719099-D33373CB-2162-46F0-9956-8C5D883BDD96Q50658602-D49EAC89-D704-45A4-BE65-1EFCFEFFECA0Q52632717-1C0BBBB6-C26B-486D-8CBD-DB1F1453AACCQ56968394-DF00D0D4-8978-46E7-B0CA-4D20BB7054A4
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Biomarkers in Breast Cancer - An Update
@ast
Biomarkers in Breast Cancer - An Update
@en
type
label
Biomarkers in Breast Cancer - An Update
@ast
Biomarkers in Breast Cancer - An Update
@en
prefLabel
Biomarkers in Breast Cancer - An Update
@ast
Biomarkers in Breast Cancer - An Update
@en
P2860
P50
P356
P1476
Biomarkers in Breast Cancer - An Update
@en
P2093
P2860
P304
P356
10.1055/S-0032-1315340
P577
2012-09-01T00:00:00Z